Detalhe da pesquisa
1.
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
BMC Psychiatry
; 22(1): 625, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151539
2.
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. / Internationale Konsenserklärung zu Screening, Diagnostik und Behandlung von Jugendlichen und Heranwachsenden mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung und gleichzeitigen Störungen durch Substanzgebrauch.
Z Kinder Jugendpsychiatr Psychother
; 50(1): 54-67, 2021 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-34397296
3.
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
Eur Addict Res
; 26(4-5): 223-232, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634814